The Temporal Effects of Anti-TGF-β1, 2, and 3 Monoclonal Antibody on Wound Healing and Hypertrophic Scar Formation
- 7 July 2005
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American College of Surgeons
- Vol. 201 (3), 391-397
- https://doi.org/10.1016/j.jamcollsurg.2005.03.032
Abstract
Background A number of studies have implicated transforming growth factor (TGF)-β1, 2, and 3 (TGF-β) in wound healing and hypertrophic scarring. We propose that TGF-β has a temporal effect on these processes. To test this hypothesis, we applied anti-TGF β1, 2, and 3 monoclonal antibody topically to our dermal ulcer model in the rabbit ear. Study design Rabbit ear wounds were treated intradermally with anti-TGF-β1, 2, and 3 antibody at early, middle, and late time points. Treated and untreated control wounds were harvested at various time points and examined histologically to quantify wound healing and scar hypertrophy. Real-time polymerase chain reaction was performed to determine TGF-β mRNA expression in the treated and control wounds. Results The early treatment group demonstrated decreased new epithelium and granulation tissue (p < 0.05 versus controls). Scars harvested on days 28 and 40 displayed no difference in scar hypertrophy. Both the middle and late treatment groups demonstrated a significant decrease in scar hypertrophy (p < 0.05). Conclusions Treated wounds from the early treatment group displayed delayed wound healing, with no reduction in scar hypertrophy. Later treatment of wounds with the same antibody, beginning 7 days after wounding, resulted in a reduction in scar hypertrophy. These results support our hypothesis and clearly demonstrate that TGF-β1, 2, and 3 have differential temporal effects during the wound-healing process, and are important for optimal wound healing in the first week after wounding; beyond 1 week, TGF-β1, 2, and 3 play a critical role in hypertrophic scar formation.Keywords
This publication has 32 references indexed in Scilit:
- Anti-TGFβ1 antibody for modulation of expression of endogenous transforming growth factor beta 1 to prevent fibrosis after plastic surgery in ratsBritish Journal of Oral and Maxillofacial Surgery, 2004
- Evaluation of Anti-TGF-β2 Antibody as a New Postoperative Anti-scarring Agent in Glaucoma SurgeryPublished by Association for Research in Vision and Ophthalmology (ARVO) ,2003
- Role of Transforming Growth Factor β in Human DiseaseNew England Journal of Medicine, 2000
- Studies in Flexor Tendon Wound Healing: Neutralizing Antibody to TGF-β1 Increases Postoperative Range of MotionPlastic and Reconstructive Surgery, 2000
- Antibody to Transforming Growth Factor Beta Reduces Collagen Production in Injured Peripheral NervePlastic & Reconstructive Surgery, 1998
- Smads and early developmental signaling by the TGFβ superfamilyGenes & Development, 1998
- Inhibition of Corneal Fibrosis by Topical Application of Blocking Antibodies to TGF?? in the RabbitCornea, 1997
- Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β)Growth Factors, 1993
- Transforming growth factor-beta: recent progress and new challenges.The Journal of cell biology, 1992
- Control of scarring in adult wounds by neutralising antibody to transforming growth factor βThe Lancet, 1992